Similar Articles
Analysis of treatment outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis on rituximab therapy
Tsvetelina Yoneva, Yana Zdravkova, Georgi Kotov, Ekaterina Ivanova Todorova, Georgi Vasilev, Rasho Rashkov, Ivan Sheytanov
DOI: 10.46497/ArchRheumatol.2023.9556
Issue: Volume 38 - Issue 3 - September 2023
1208
985
Performance of the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for antineutrophil cytoplasmic antibody-associated vasculitis in previously diagnosed adult patients from Türkiye
Sedat Yilmaz, Hamit Kucuk, Merve Sungur Ozgunen, Riza Can Kardas, Duygu Tecer, Ibrahim Vasi, Muhammet Cinar, Mehmet Akif Ozturk
DOI: 10.46497/ArchRheumatol.2024.10268
Issue: Volume 39 - Issue 2 - June 2024
898
744
Prevalence and characteristics of bronchiectasis in ANCA-associated vasculitis: A systematic review and meta-analysis
Yu Gu, Ting Zhang, Wenyan Zhu, Yang Han, Juhong Shi
DOI: 10.46497/ArchRheumatol.2024.10352
Issue: Volume 39 - Issue 3 - September 2024
865
688
Diastolic dysfunction in Behçet's disease and its relationship with clinical manifestations of the disease: A case-control study
Gizem Varkal, Rabia Eker Akıllı, İpek Türk, Zeynep Tüzün, Burak Mete, Süleyman Özbek
DOI: 10.46497/ArchRheumatol.2024.10772
Issue: Volume 39 - Issue 4 - December 2024
32
103
Relationship between IgA vasculitis and prothrombotic risk factors: A prospective, case-control study
Cengiz Zeybek, Ahmet Bolat, Orhan Gürsel, Bülent Hacıhamdioğlu, Ahmet Emin Kürekçi
DOI: 10.46497/ArchRheumatol.2024.10711
Issue: Volume 39 - Issue 4 - December 2024
33
86